• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1969年至1989年间,卡介苗接种覆盖率变化对瑞典出生儿童结核病发病率的影响。

The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.

作者信息

Romanus V, Svensson A, Hallander H O

机构信息

Department of Epidemiology, National Bacteriological Laboratory, Stockholm, Sweden.

出版信息

Tuber Lung Dis. 1992 Jun;73(3):150-61. doi: 10.1016/0962-8479(92)90149-E.

DOI:10.1016/0962-8479(92)90149-E
PMID:1421348
Abstract

In April 1975, the mass vaccination of newborns against tuberculosis was replaced by selective vaccination of groups at risk. BCG coverage fell from more than 95% before 1974 to 1.8% between 1975 and 1982 and thereafter reached an average of 13.7% up to 1989. The cumulative incidence of tuberculosis before 5 years of age was estimated among children born in Sweden during periods of high, low and moderate increasing BCG coverage. The incidence figures per 100,000 children was 0.8, 3.9 and 2.9, respectively, for children born to Swedish parents and 2.6, 39.4 and 13.2, respectively, for those born to foreign parents. The observed incidence of tuberculosis among non-BCG vaccinated children born to Swedish parents was within the expected limits given by a prognostic model based on the natural change of the risk of infection. The effectiveness of the selective BCG vaccination programme, which was intensified after 1981 for the second generation of immigrants, was estimated to 0.82 (95% confidence interval 0.38, 0.95) assuming that there was no change of the risk of infection for children born to foreign parents over the period studied. From April 1975 to December 1989, tuberculosis was notified in 85 children born in Sweden during the same period, 7 of them were BCG vaccinated and 78 non-vaccinated, 45 were symptomatic, 3 of them with disseminated tuberculosis.

摘要

1975年4月,新生儿大规模结核病疫苗接种被针对高危人群的选择性疫苗接种所取代。卡介苗接种覆盖率从1974年前的95%以上降至1975年至1982年期间的1.8%,此后到1989年平均达到13.7%。对瑞典出生的儿童在卡介苗接种覆盖率高、低及中等增长期间5岁前结核病的累积发病率进行了估算。瑞典籍父母所生孩子每10万名儿童中的发病率分别为0.8、3.9和2.9,外籍父母所生孩子的发病率分别为2.6、39.4和13.2。瑞典籍父母所生未接种卡介苗儿童中观察到的结核病发病率在基于感染风险自然变化的预后模型给出的预期范围内。假设在所研究期间外籍父母所生孩子的感染风险没有变化,1981年后针对第二代移民加强的选择性卡介苗接种计划的有效性估计为0.82(95%置信区间0.38,0.95)。1975年4月至1989年12月期间,瑞典同期出生的85名儿童中通报了结核病,其中7名接种了卡介苗,78名未接种,45名有症状,其中3名患有播散性结核病。

相似文献

1
The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.1969年至1989年间,卡介苗接种覆盖率变化对瑞典出生儿童结核病发病率的影响。
Tuber Lung Dis. 1992 Jun;73(3):150-61. doi: 10.1016/0962-8479(92)90149-E.
2
Selective BCG vaccination in a country with low incidence of tuberculosis.在结核病低发国家进行选择性卡介苗接种。
Euro Surveill. 2006;11(3):14-7.
3
Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.停止卡介苗接种六年的经验。1. 结核感染和疾病风险。
Tuber Lung Dis. 1993 Jun;74(3):167-72. doi: 10.1016/0962-8479(93)90006-J.
4
[BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France].[法国私人医疗执业中卡介苗接种覆盖率:法国强制接种结束七个月后两岁以下儿童的首批数据]
Arch Pediatr. 2009 May;16(5):489-95. doi: 10.1016/j.arcped.2009.01.006. Epub 2009 Mar 21.
5
The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.感染艾滋病毒儿童发生播散性卡介苗(BCG)病的风险。
Vaccine. 2007 Jan 2;25(1):14-8. doi: 10.1016/j.vaccine.2006.07.020. Epub 2006 Aug 1.
6
Risk factors associated with latent tuberculosis infection in Mexican American children.墨西哥裔美国儿童潜伏性结核感染的相关风险因素。
Pediatrics. 2005 Jun;115(6):e647-53. doi: 10.1542/peds.2004-1685.
7
Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.北欧国家中卡介苗接种对结核病低风险人群的保护作用证据。
Int J Tuberc Lung Dis. 2009 Apr;13(4):440-5.
8
BCG in Finland: changing from a universal to a selected programme.芬兰的卡介苗接种:从普遍接种计划转变为选择性接种计划。
Euro Surveill. 2006;11(3):18-20.
9
[BCG vaccination in West Germany?].[西德的卡介苗接种?]
Pneumologie. 1994 Feb;48(2):151-5.
10
Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.香港出生时接种卡介苗的队列中卡介苗再接种计划的效果。
Int J Tuberc Lung Dis. 2001 Aug;5(8):717-23.

引用本文的文献

1
Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in Mice.新生儿皮下接种卡介苗可减少小鼠动脉粥样硬化斑块数量及斑块内巨噬细胞含量。
Biology (Basel). 2022 Oct 15;11(10):1511. doi: 10.3390/biology11101511.
2
Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study.重新评估英格兰和威尔士普遍进行学龄期卡介苗接种的证据:重新评估和更新建模研究。
BMJ Open. 2022 Jan 11;12(1):e031573. doi: 10.1136/bmjopen-2019-031573.
3
Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination.
卡介苗(BCG)普遍接种停止后儿童结核病的流行病学。
Sci Rep. 2021 Aug 5;11(1):15902. doi: 10.1038/s41598-021-95294-y.
4
Paediatric tuberculosis during universal and selective Calmette-Guérin vaccination policy: a nationwide population-based retrospective study, Finland, 1995-2015.儿童结核病在普遍和选择性卡介苗接种政策下的发病情况:1995-2015 年芬兰全国性基于人群的回顾性研究。
Euro Surveill. 2021 Mar;26(11). doi: 10.2807/1560-7917.ES.2021.26.11.1900711.
5
BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny.卡介苗作为精准疫苗开发的案例研究:来自疫苗异质性、训练免疫和免疫个体发生学的经验教训。
Front Microbiol. 2020 Mar 11;11:332. doi: 10.3389/fmicb.2020.00332. eCollection 2020.
6
Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.评估 2005 年英格兰 BCG 政策变化的效果:一项回顾性队列研究,2000 年至 2015 年。
Euro Surveill. 2019 Dec;24(49). doi: 10.2807/1560-7917.ES.2019.24.49.1900220.
7
Evaluating the neonatal BCG vaccination programme in Ireland.评估爱尔兰的新生儿卡介苗接种计划。
Arch Public Health. 2016 Jul 13;74:28. doi: 10.1186/s13690-016-0141-0. eCollection 2016.
8
"To BCG or not to BCG, that is the question!". The challenge of BCG vaccination: Why can't we get it right?“接种卡介苗还是不接种卡介苗,这是个问题!”卡介苗接种的挑战:我们为何做不对?
Paediatr Child Health. 2003 Mar;8(3):141-4. doi: 10.1093/pch/8.3.141.
9
Mycobacterial species causing pulmonary tuberculosis at the korle bu teaching hospital, accra, ghana.在加纳阿克拉的科勒布教学医院导致肺结核的分枝杆菌种类。
Ghana Med J. 2007 Jun;41(2):52-7. doi: 10.4314/gmj.v41i2.55293.
10
Protective effect of neonatal BCG vaccines against tuberculous meningitis.新生儿卡介苗对结核性脑膜炎的保护作用。
Bosn J Basic Med Sci. 2004 Feb;4(1):46-9. doi: 10.17305/bjbms.2004.3460.